Literature DB >> 33406590

A Comparison of the Epidemiology, Clinical Features, and Treatment of Acute Osteomyelitis in Hospitalized Children in Latvia and Norway.

Elise Evja Thingsaker1,2, Urzula Nora Urbane3, Jana Pavare1,3.   

Abstract

Background and objectives: Paediatric acute osteomyelitis (AO) may result in major life-threatening and limb-threatening complications if not recognized and treated early. The management of AO may depend on local microbial prevalence and virulence factors. This study compares the approach to paediatric AO in hospitals in two countries-Latvia and Norway. Materials and
Methods: The study includes patients with AO hospitalized in the paediatric department in the Norwegian hospital Sørlandet Sykehus Kristiansand (SSK), in the period between the 1st of January 2012 and the 31st of December 2019. The results from SSK are compared to the results of a published study of AO in patients hospitalized at the Children's Clinical University Hospital (CCUH) in Riga, Latvia.
Results: The most isolated pathogen from cultures in both hospitals was S. aureus (methicillin-sensitive). The lower extremity was the most affected body part (75% in CCUH, 95% in SSK), the main clinical symptom was pain (CCUH 92%, SSK 96.6%). Deep culture aspiration was most often taken intraoperatively in CCUH (76.6%) and percutaneously in SSK (44.8%). Oxacillin was the most applied antibiotic in CCUH (89.4%), and Cloxacillin in SSK (84.6%). Combined treatment with anti-Staphylococcal penicillins and Clindamycin was administered in 25.5% and 33.8% of CCUH and SSK patients, respectively. The median duration of the intravenous antibacterial treatment in CCUH and SSK was 15 and 10 days, respectively, and a switch to oral therapy was mainly made at discharge in both hospitals. The median total duration of antibiotic treatment was 25 days in CCUH and 35 days in SSK. 75% of CCUH and 10.3% of SSK patients were treated surgically. Complications were seen in 47% of patients in CCUH and in 38% in SSK. Conclusions: The transition to oral antibacterial treatment in both hospitals was delayed, which suggests a lack of criteria for discontinuation of intravenous therapy and could potentially contribute to longer hospitalization, higher cost of treatment and risk of complications. The use of more invasive techniques for deep culturing and significantly more common surgical interventions could possibly be linked to a higher complication rate in AO patients treated at the Latvian hospital.

Entities:  

Keywords:  Staphylococcus aureus; acute osteomyelitis; antibacterial therapy; children

Mesh:

Substances:

Year:  2021        PMID: 33406590      PMCID: PMC7824191          DOI: 10.3390/medicina57010036

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  52 in total

Review 1.  Haematogenous acute and subacute paediatric osteomyelitis: a systematic review of the literature.

Authors:  J Dartnell; M Ramachandran; M Katchburian
Journal:  J Bone Joint Surg Br       Date:  2012-05

2.  Bone and Joint Infections.

Authors:  Jesús Saavedra-Lozano; Oana Falup-Pecurariu; Saul N Faust; Hermann Girschick; Nico Hartwig; Sheldon Kaplan; Mathie Lorrot; Elpis Mantadakis; Heikki Peltola; Pablo Rojo; Theoklis Zaoutis; Anton LeMair
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

3.  Epidemiology and spa-type diversity of meticillin-resistant Staphylococcus aureus in community and healthcare settings in Norway.

Authors:  F Di Ruscio; J V Bjørnholt; K W Larssen; T M Leegaard; A E Moen; B F de Blasio
Journal:  J Hosp Infect       Date:  2017-12-28       Impact factor: 3.926

4.  Antibiotic therapy of bone and joint infections in children: proposals of the French Pediatric Infectious Disease Group.

Authors:  M Lorrot; Y Gillet; C Gras Le Guen; E Launay; R Cohen; E Grimprel
Journal:  Arch Pediatr       Date:  2017-12       Impact factor: 1.180

Review 5.  Bone and joint infections in children.

Authors:  Kathleen Gutierrez
Journal:  Pediatr Clin North Am       Date:  2005-06       Impact factor: 3.278

6.  Osteomyelitis: approach to diagnosis and treatment.

Authors:  Joseph M Fritz; Jay R McDonald
Journal:  Phys Sportsmed       Date:  2008-12       Impact factor: 2.241

Review 7.  Current imaging concepts in pediatric osteomyelitis.

Authors:  J G Blickman; C E van Die; J W J de Rooy
Journal:  Eur Radiol       Date:  2004-03       Impact factor: 5.315

Review 8.  Acute infectious osteomyelitis in children: new treatment strategies for an old enemy.

Authors:  Sabrina Congedi; Chiara Minotti; Carlo Giaquinto; Liviana Da Dalt; Daniele Donà
Journal:  World J Pediatr       Date:  2020-05-11       Impact factor: 2.764

9.  Duration of antimicrobial therapy for acute suppurative osteoarticular infections.

Authors:  G A Syrogiannopoulos; J D Nelson
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

10.  The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006 - 2017.

Authors:  Petter Elstrøm; Elisabeth Astrup; Kristin Hegstad; Ørjan Samuelsen; Hege Enger; Oliver Kacelnik
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

View more
  2 in total

1.  Ultrasound Instead of X-Ray to Diagnose Neonatal Fractures: A Feasibility Study Based on a Case Series.

Authors:  Jing Liu; Li Zhang; Ru-Xin Qiu
Journal:  Front Pediatr       Date:  2022-05-26       Impact factor: 3.569

2.  Osteoarticular Infections in Pediatric Hospitals in Europe: A Prospective Cohort Study From the EUCLIDS Consortium.

Authors:  Andreas Trobisch; Nina A Schweintzger; Daniela S Kohlfürst; Manfred G Sagmeister; Matthias Sperl; Andrea J Grisold; Gebhard Feierl; Jethro A Herberg; Enitan D Carrol; Stephane C Paulus; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Miriam Cebey-López; Irene Rivero-Calle; Navin P Boeddha; Paul-Michael Agapow; Fatou Secka; Suzanne T Anderson; Uta Behrends; Uwe Wintergerst; Karl Reiter; Federico Martinon-Torres; Michael Levin; Werner Zenz
Journal:  Front Pediatr       Date:  2022-05-04       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.